£85.77

Academic Press Post-Authorization Safety Studies of Medicinal Products: The PASS Book

Price data last checked 52 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£86 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 39 days • 39 data points (No recent data available)

Historical
Generating forecast...
£85.77 £81.48 £83.20 £84.91 £86.63 £88.34 £90.06 11 March 2026 20 March 2026 30 March 2026 08 April 2026 18 April 2026

Price Distribution

Price distribution over 39 days • 1 price levels

Days at Price
39 days 0 10 20 29 39 £86 Days at Price

Price Analysis

Most common price: £86 (39 days, 100.0%)

Price range: £86 - £86

Price levels: 1 different prices over 39 days

Description

Post-Authorization Safety Studies of Medicinal Products: The PASS Book bridges the gap in the literature by providing a complete look at post-authorization safety studies and important pharmacoepidemiology and pharmacovigilance aspects. It covers various types and limitations of active surveillance programs, including the use of large databases and disparate data sources for rapid signal detection, as well as novel and advanced design and analysis approaches for causal interference from observational data. This book serves as an important reference for pharmacovigilance scientists and pharmacoepidemiologists who are searching for the appropriate study design to answer safety research questions. Readers will be able to effectively and efficiently design and interpret findings from post-authorization safety studies with the goal of improving the benefit-risk balance of a drug in order to optimize patient safety. Discusses all types of observational studies in post-marketing drug safety assessment, from spontaneous reporting systems, to pragmatic trials, with examples from real-world settings Presents various types of post-authorization safety studies Offers solutions to the common challenges in the design and conduct of these studies Highlights active surveillance programs, including common data models for rapid signal detection of drug safety issues

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Principles and Practice of Pharmacovigilance and Drug Safety
97% match

Principles and Practice of Pharmacovigilance and Drug Safety

£115.72 14 Jan 2026
Pharmacoepidemiology and Pharmacovigilance: Synergistic Tools to Better Investigate Drug Safety
97% match

Pharmacoepidemiology and Pharmacovigilance: Synergistic Tools to Better Investigate Drug Safety

Academic Press

£95.79 13 Jan 2026
Pharmacovigilance: A Practical Approach
97% match

Pharmacovigilance: A Practical Approach

£67.64 13 Jan 2026
Pharmacovigilance: A Practical Approach
97% match

Pharmacovigilance: A Practical Approach

Elsevier

£77.65 08 Jan 2026
Stephens' Detection and Evaluation of Adverse Drug Reactions: Principles and Practice
96% match

Stephens' Detection and Evaluation of Adverse Drug Reactions: Principles and Practice

Wiley

£187.00 13 Jan 2026
Pharmacovigilance
96% match

Pharmacovigilance

£215.00 12 Jan 2026
Quantitative Drug Safety and Benefit Risk Evaluation: Practical and Cross-Disciplinary Approaches (Chapman & Hall/CRC Biostatistics Series)
96% match

Quantitative Drug Safety and Benefit Risk Evaluation: Practical and Cross-Disciplinary Approaches (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£93.00 25 Jan 2026
Stephens' Detection of New Adverse Drug Reactions
96% match

Stephens' Detection of New Adverse Drug Reactions

Wiley

£161.89 26 Jan 2026
Drug Safety: Pharmacovigilance & Pharmacoepidemiology & Database
96% match

Drug Safety: Pharmacovigilance & Pharmacoepidemiology & Database

CREATESPACE

£90.64 09 Mar 2026
Cobert's Manual Of Drug Safety And Pharmacovigilance (Fourth Edition): 4th Edition
96% match

Cobert's Manual Of Drug Safety And Pharmacovigilance (Fourth Edition): 4th Edition

£49.00 08 Jan 2026
Medical Product Safety Evaluation: Biological Models and Statistical Methods (Chapman & Hall/CRC Biostatistics Series)
96% match

Medical Product Safety Evaluation: Biological Models and Statistical Methods (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£62.35 02 Mar 2026
Medical Product Regulatory Affairs: Pharmaceuticals, Diagnostics, Medical Devices
96% match

Medical Product Regulatory Affairs: Pharmaceuticals, Diagnostics, Medical Devices

Wiley

£71.75 13 Jan 2026
Advanced Issue Resolution in Safety Pharmacology
96% match

Advanced Issue Resolution in Safety Pharmacology

Academic Press

£109.79 10 Mar 2026
Pharmaceutical Medicine (Oxford Specialist Handbooks)
96% match

Pharmaceutical Medicine (Oxford Specialist Handbooks)

Oxford University Press

£56.99 26 Jan 2026
Benefit-Risk Assessment in Pharmaceutical Research and Development (Chapman & Hall/CRC Biostatistics Series)
96% match

Benefit-Risk Assessment in Pharmaceutical Research and Development (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£75.00 27 Feb 2026
Regulatory Affairs in the Pharmaceutical Industry
96% match

Regulatory Affairs in the Pharmaceutical Industry

Academic Press

£131.79 10 Mar 2026
Pharmaceutical Statistics: MBSW 39, Muncie, Indiana, USA, May 16-18, 2016: 218 (Springer Proceedings in Mathematics & Statistics, 218)
96% match

Pharmaceutical Statistics: MBSW 39, Muncie, Indiana, USA, May 16-18, 2016: 218 (Springer Proceedings in Mathematics & Statistics, 218)

Springer

£85.80 15 Apr 2026
Theory of Drug Development: 61 (Chapman & Hall/CRC Biostatistics Series)
96% match

Theory of Drug Development: 61 (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£80.00 13 Apr 2026
Mann's Pharmacovigilance
96% match

Mann's Pharmacovigilance

Wiley

£153.29 25 Jan 2026
Statistics In the Pharmaceutical Industry: 14 (Chapman & Hall/CRC Biostatistics Series)
96% match

Statistics In the Pharmaceutical Industry: 14 (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£141.70 08 Feb 2026
The Textbook of Pharmaceutical Medicine
96% match

The Textbook of Pharmaceutical Medicine

BMJ Books

£129.26 13 Jan 2026
Pharmaco-Vigilance from A to Z: Adverse Drug Event Surveillance
96% match

Pharmaco-Vigilance from A to Z: Adverse Drug Event Surveillance

Wiley-Blackwell

£81.69 08 Mar 2026
Medication Safety: A Guide for Health Care Facilities
96% match

Medication Safety: A Guide for Health Care Facilities

American Society of Health-System Pharmacists

£75.49 09 Mar 2026
Theory of Drug Development (Chapman & Hall/CRC Biostatistics Series)
96% match

Theory of Drug Development (Chapman & Hall/CRC Biostatistics Series)

CRC Press

£60.89 06 Mar 2026